Stocks & Investing
Stocks and Investing
Stocks and Investing
Tue, September 11, 2018
[ Tue, Sep 11th 2018
] - WOPRAI
[ Tue, Sep 11th 2018
] - WOPRAI
[ Tue, Sep 11th 2018
] - WOPRAI
[ Tue, Sep 11th 2018
] - WOPRAI
[ Tue, Sep 11th 2018
] - WOPRAI
[ Tue, Sep 11th 2018
] - WOPRAI
[ Tue, Sep 11th 2018
] - WOPRAI
[ Tue, Sep 11th 2018
] - WOPRAI
Mon, September 10, 2018
[ Mon, Sep 10th 2018
] - WOPRAI
[ Mon, Sep 10th 2018
] - WOPRAI
[ Mon, Sep 10th 2018
] - WOPRAI
[ Mon, Sep 10th 2018
] - WOPRAI
[ Mon, Sep 10th 2018
] - WOPRAI
[ Mon, Sep 10th 2018
] - WOPRAI
[ Mon, Sep 10th 2018
] - WOPRAI
[ Mon, Sep 10th 2018
] - WOPRAI
[ Mon, Sep 10th 2018
] - WOPRAI
[ Mon, Sep 10th 2018
] - WOPRAI
[ Mon, Sep 10th 2018
] - WOPRAI
[ Mon, Sep 10th 2018
] - WOPRAI
Fri, September 7, 2018
[ Fri, Sep 07th 2018
] - WOPRAI
[ Fri, Sep 07th 2018
] - WOPRAI
Salim Syed Initiated (UBX) at Strong Buy and Held Target at $330 on, Sep 7th, 2018
Salim Syed of Mizuho, Initiated "Unity Biotechnology, Inc." (UBX) at Strong Buy and Held Target at $330 on, Sep 7th, 2018.
Salim has made no other calls on UBX in the last 4 months.
There are 2 other peers that have a rating on UBX. Out of the 2 peers that are also analyzing UBX, 0 agree with Salim's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Salim
- Matthew Harrison of "Morgan Stanley" Initiated at Buy and Held Target at $250 on, Tuesday, May 29th, 2018
- Yigal Nochomovitz of "Citigroup" Initiated at Strong Buy and Held Target at $320 on, Tuesday, May 29th, 2018
